Human breast cancer cells and normal mammary epithelial cells: Retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4642-4651

  Chen, Anne C ^a   Guo, Xiaojia ^a   Derguini, Fadila ^b   Gudas, Lorraine J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID BINDING PROTEIN; RETINOL;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CELL DIFFERENTIATION; CELL TYPE; DRUG RECEPTOR BINDING; EPITHELIUM CELL; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; VITAMIN METABOLISM;

BREAST; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIAL CELLS; FEMALE; HUMANS; KINETICS; RETINOL-BINDING PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRITIUM; TUMOR CELLS, CULTURED; VITAMIN A;

EID: 0030882328     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Gudas, L. J., Sporn, M. B., and Roberts, A. B. Cellular biology and biochemistry of the retinoids. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, pp. 443-520. New York: Raven Press, 1994.
2. Moon, R. C., Mehta, R. G., and Rao, K. V. N. Retinoids and cancer in experimental animals. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry and Medicine, pp. 573-596. New York: Raven Press, 1994.
3. Hong, W. K., and Itri, L. M. Retinoids and human cancer. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, pp. 597-630. New York: Raven Press, 1994.
4. Warrell, R. P., Jr., de The, H., Wang, Z-Y., and Degos, L. Acute promyelocytic leukemia. N. Engl. J. Med., 329: 177-189, 1993.
5. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. The retinoid receptors. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, pp. 319-350. New York: Raven Press, 1994.
6. Kastner, P., Leid, M., and Chambon, P. The role of nuclear retinoic acid receptors in the regulation of gene expression. In: R. Blomhoff (ed.), Vitamin A in Health and Disease, pp. 189-238. New York: Marcel Dekker, Inc., 1994.
7. Dawson, M. I., Chao, W., Pine, P., Jong, L., Hobbs, P. D., Rudd, C. K., Quick, T. C., Niles, R. M., Zhang, X., Lombardo, A., Ely, K. R., Shroot, B., and Fontana, J. A. Correlation of retinoid binding affinity to retinoic acid receptor a with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res., 55: 4446-4451, 1995.
8. Fontana, J. A. Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp. Cell Biol., 55: 136-144, 1987.
9. Fontana, J. A., Hobbs, P. D., and Dawson, M. I. Inhibition of mammary carcinoma growth by retinoidal benzoic acid derivatives. Exp. Cell Biol., 56: 254-263, 1988.
10. Koga, M., and Sutherland, R. L. Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antiestrogen to inhibit human breast cancer cell proliferation. J. Steroid Biochem. Mol. Biol., 39: 455-460, 1991.
11. Marth, C., Bock, G., and Daxenbichler, G. Effect of 4-hydroxyphenyl-retinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J. Natl. Cancer Inst., 75: 871-875, 1985.
12. Shao, Z. M., Dawson, M. I., Li, X. S., Rishi, A. K., Han, Q. X., Ordonez, J. V., Shroot, B., and Fontana, J. A. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
13. Teelmann, K., Tsukaguchi, T., Klaus, M., and Eliason, J. F. Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans- and 13-cis-retinoic acid on rat breast cancer. Cancer Res., 53: 2319-2325, 1993.
14. van der Leede, B. M., van den Brink, C. E., and van der Saag, P. T. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines. Mol. Carcinog., 8: 112-122, 1993.
15. Wetherall, N. T., and Taylor, C. M. The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells. Eur. J. Cancer Clin. Oncol., 22: 53-59, 1986.
16. Widschwendter, M., Daxenbichler, G., Dapunt, O., and Marth, C. Effects of retinoic acid and γ-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells. Cancer Res., 55: 2135-2139, 1995.
17. Lee, P-P. H., Lee, M-T., Darcy, K. M., Shudo, K., and Ip, M. M. Modulation of normal mammary epithelial cell proliferation, morphogenesis, and functional differentiation by retinoids: a comparison of the retinobenzoic acid derivative RE80 with retinoic acid. Endocrinology. 136: 1707-1717, 1995.
18. Anzano, M. A., Byers, S. W., Smith, J. M., Peer, C. W., Mullen, L. T., Brown, C. C., Roberts, A. B., and Sporn, M. B. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res., 54: 4614-4617, 1994.
19. Moon, R. C., Grubbs, C. J., and Sporn, M. B. Inhibition of 7,12-dimethylbenzanthracene induced mammary carcinogenesis by retinyl acetate. Cancer Res., 36: 2626-2630, 1976.
20. McCormick, D. L., Burns, F. J., and Albert, R. E. Inhibition of rat mammary carcinogenesis by short dietary exposures to retinyl acetate. Cancer Res., 40: 1140-1143, 1980.
21. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ., 5: 133-141, 1994.
22. van der Burg, B., van der Leede, B-J., Kwakkenbos-Isbrücker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol., 91: 149-157, 1993.
23. Rubin, M., Fenig, E., Rosenauer, A., Menendez-Botet, C., Achkar, C., Bentel, J. M., Yahalom, J., Mendelsohn, J., and Miller, W. H., Jr. 9-cis Retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res., 54: 6549-6556, 1994.
24. Roman, S. D., Clarke, C. L., Hall, R. E., Alexander, I. E., and Sutherland, R. L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res., 52: 2236-2242, 1992.
25. Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S. J., and Swisshelm, K. Expression of retinoic acid receptor β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ., 6: 1077-1088, 1995.
26. Liu, Y., Lee, M-I., Wang, H-G., Li, Y., Hashimoto, Y., Klaus, M., Reed, J. C., and Zhang, X-K. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol., 16: 1138-1149, 1996.
27. Li, X-S., Shao, Z-M., Sheikh, M. S., Eiseman, J. L., Sentz, D., Jetten, A. M., Chen, J-C., Dawson, M. I., Aisner, S., Rishi, A. K., Gutierrez, P., Schnapper, L., and Fontana, J. A. Retinoic acid nuclear receptor β inhibits breast carcinoma anchorage independent growth. J. Cell. Physiol., 165: 449-458, 1995.
28. Lacroix, A., and Lippman, M. E. Binding of retinoids to human breast cancer cell lines and their effects on cell growth. J. Clin. Invest., 65: 586-591, 1980.
29. Sheikh, M. S., Shao, Z. M., Li, X. S., Dawson, M., Jetten, A. M., Wu, S., Conley, B. A., Garcia, M., Rochefort, H., and Fontana, J. A. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-α acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem., 269: 21440-21447, 1994.
30. van der Leede, B-J., Folkers, G. E., van den Brink, C. E., van der Saag, P. T., and van der Burg, B. Retinoic acid receptor α isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol. Cell. Endocrinol., 109: 77-86, 1995.
31. Roman, S. D., Ormandy, C. J., Manning, D. L., Blarney, R. W., Nicholson, R. I., Sutherland, R. L., and Clarke, C. L. Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res., 53: 5940-5945, 1993.
32. Rishi, A. K., Shao, Z-M., Baumann, R. G., Li, X-S., Sheikh, M. S., Kimura, S., Bashirelahi, N., and Fontana, J. A. Estradiol regulation of the human retinoic acid receptor α gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res., 55: 4999-5006, 1995.
33. Pratt, M. A. C., Deonarine, D., Teixeira, C., Novosad, D., Tate, B. F., and Grippo, J. F. The AF-2 region of the retinoic acid receptor a mediates retinoic acid inhibition of estrogen receptor function in breast cancer cells. J. Biol. Chem., 271: 20346-20352, 1996.
34. Blaner, W. S., and Olson, J. A. Retinol and retinoic acid metabolism. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, pp. 229-256. New York: Raven Press, 1994.
35. Kurlandsky, S. B., Xiao, J. H., Duell, E. A., Voorhees, J. J., and Fisher, G. J. Biological activity of all-trans retinol requires metabolic conversion to all-trans retinoic acid and is mediated through activation of nuclear retinoid receptors in human keratinocytes. J. Biol. Chem., 269: 32821-32827, 1994.
36. Randolph, R. K., and Simon, M. Characterization of retinol metabolism in cultured human epidermal keratinocytes. J. Biol. Chem., 268: 9198-9205, 1993.
37. Siegenthaler, G., Saurat, J-H., and Ponec, M. Retinol and retinal metabolism: relationship to the state of differentiation of cultured human keratinocytes. Biochem. J., 268: 371-378, 1990.
38. Torma, H., and Vahlquist, A. Vitamin A esterification in human epidermis: a relationship to keratinocyte differentiation. J. Invest. Dermatol., 94: 132-138, 1990.
39. Derguini, F., Nakanishi, K., Hämmerling, U., Chua, R., Eppinger, T., Levi, E., and Buck, J. 13,14-Dihydroxy-retinol, a new bioactive retinol metabolite. J. Biol. Chem., 270: 19975-18880, 1995.
40. Buck, J., Grün, F., Kimura, S., Noy, N., Derguini, F., and Hammerling, U. Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology. J. Exp. Med., 178: 675-680, 1993.
41. Derguini, F., Nakanishi, K., Hämmerling, U., and Buck, J. Intracellular signaling activity of synthetic (14R)-, (14S)-, and (14RS)-14-hydroxy-4,14-retro-retinol. Biochemistry, 33: 623-628, 1994.
42. Derguini, F., Nakanishi, K., Buck, J., Hämmerling, U., and Grün, F. Spectroscopic studies of anhydroretinol, an endogenous mammalian and insect retro-retinol. Angew. Chem. Int. Ed. Engl., 33: 1837-1839, 1994.
43. Achkar, C. C., Derguini, F., Blumberg, B., Langston, A., Levin, A. A., Speck, J., Evans, R. M., Bolado, J., Jr., Nakanishi, K., Buck, J., and Gudas, L. J. 4-Oxoretinol, a new natural ligand and transactivator of the retinoic acid receptors. Proc. Natl. Acad. Sci. USA, 93: 4879-4884, 1996.
44. Blumberg, B., Bolado, J., Jr., Derguini, F., Craig, A. G., Moreno, T. A., Charkaravarti, D., Heyman, R. A., Buck, J., and Evans, R. M. Novel RAR ligands in Xenopus embryos. Proc. Natl. Acad. Sci. USA, 93: 4873-4878, 1996.
45. Modiano, M., Dalton, W., Lippman, S., Joffe, L., Booth, A. R., and Meyskens, F. L., Jr. Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma. Invest. New Drugs, 8: 317-319, 1990.
46. Costa, A., Formelli, F., Chiesa, F., Decensi, A., De Palo, G., and Veronesi, U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res., 54 (Suppl.): 2032s-2037s, 1994.
47. Rotmensz, N., DePalo, G., Formelli, F., Ciosta, A., Marubini, E., Campa, T., Crippa, A., Danesini, G. M., Delle Grottaglie, M., and Di Mauro, M. G. Long-term tolerability of fenretinide (4-HPR) in breast cancer patients. Eur. J. Cancer, 27: 1127-1131, 1991.
48. Cobleigh, M. A., Dowlatshahi, K., Deutsch, T. A., Mehta, T. A., Moon, R. C., Minn, F., Benson, A. B., III, Rademaker, A. W., Ashenhurst, J. B., Wade, J. L., III, and Walter, J. Phase I/II trial of tamoxifen with or without fenretinide, an analogue of vitamin A, in women with metastatic breast cancer. J. Clin. Oncol., 11: 474-477, 1993.
49. Formelli, F., Clerici, M., Campa, T., Di Mauro, M. G., Magni, A., Mascotti, G., Moglia, D., De Palo, G., Costa, A., and Veronesi, U. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J. Clin. Oncol., 11: 2036-2042, 1993.
50. Fanjul, A. N., Delia, D., Pierotti, M. A., Rideout, D., Qiu, J., and Pfahl, M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem., 271: 22441-22446, 1996.
51. Kazmi, S. M. I., Plante, R. K., Visconti, V., and Lau, C. L. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res., 56: 1056-1062, 1996.
52. Pellegrini, R., Mariotti, A., Tagliabue, E., Bressan, R., Bunone, G., Coradini, D., Della Valle, G., Formelli, F., Cleris, L., Radice, P., Pierotti, M. A., Colnaghi, M. I., and Ménard, S. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl)retinamide. Cell Growth Differ., 6: 863-869, 1995.
53. Sheikh, M. S., Shao, Z. M., Li, X. S., Ordonez, J. V., Conley, B. A., Wu, S., Dawson, M. I., Han, Q. X., Chao, W. R., and Quick, T. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis (Lond.), 16: 2477-2486, 1995.
54. Stampfer, M. R. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Meth., 9: 107-116, 1985.
55. Stampfer, M. R., and Bartley, J. C. Human mammary epithelial cells in culture: differentiation and transformation, pp. 1-24. In: R. Dickson and M. Lippman (eds.), Breast Cancer: Cellular and Molecular Biology. Norwell, MA: Martinus Nijhoff, 1988.
56. Boylan, J. F., and Gudas, L. J. The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J. Biol. Chem., 267: 21486-21491, 1992.
57. McClean, S. W., Ruddel, M. E., Gross, E. G., DiGiovanna, J. J., and Peck, G. L. Liquid chromatographic assay for retinol (vitamin A) and retinol analogs in therapeutic trials. Clin. Chem., 28: 693-696, 1982.
58. Chen, A. C., and Gudas, L. J. An analysis of retinoic acid-induced gene expression and metabolism in AB1 embryonic stem cells. J. Biol. Chem., 277: 14971-14980, 1996.
59. Stoner, C. M., and Gudas, L. J. Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells. Cancer Res., 49: 1497-1504, 1989.
60. Jing, Y., Waxman, S., and Mira-y-Lopez, R. The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells. Cancer Res., 57: 1668-1672, 1997.
61. Bhat, P., and Lacroix, A. Metabolism of retinol and retinoic acid in N-methyl-N-nitrosourea-induced mammary carcinoma in rats. Cancer Res., 49: 139-144, 1989.
62. Han, I. S., and Choi, J. H. Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells. J. Clin. Endocrinol. Metab., 81: 2069-2075, 1996.
63. Hellmold, H., Lamb, J. G., Wyss, A., Gustafsson, J-A., and Warner, M. Developmental and endocrine regulation of P450 isoforms in rat breast. Mol. Pharmacol., 48: 630-638, 1995.
64. Roberts, E. S., Vaz, A. D. N., and Coon, M. J. Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol, and retinal. Mol. Pharmacol., 41: 427-433, 1992.
65. Raner, G. M., Vaz, A. D. N., and Coon, M. J. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral. Mol. Pharmacol., 49: 515-522, 1996.
66. Leo, M. A., Lasker, J. M., Raucy, J. L., Kim, C. I., Black, M., and Lieber, C. S. Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch. Biochem. Biophys., 269: 305-312, 1989.
67. White, J. A., Guo-Y-D., Baetz, K., Beckett-Jones, B., Bonasoro, J., Hsu, K. E., Dilworth, F. J., Jones, G., and Petkovich, M. Identification of the retinoic acid-inducible all-trans-retinoic 4-hydroxylase. J. Biol. Chem., 271: 29922-29927, 1996.
68. Roberts, A. B., Frolik, C. A., Nichols, M. D., and Sporn, M. B. Retinoid-dependent induction of the in vivo and in vitro metabolism of retinoic acid in tissues of the vitamin A-deficient hamster. J. Biol. Chem., 254: 6303-6309, 1979.
69. Roberts, A. B., Lamb, L. C., and Sporn, M. B. Metabolism of all-trans-retinoic acid in hamster liver microsomes: oxidation of 4-hydroxy-to 4-keto-retinoic acid. Arch. Biochem. Biophys., 199: 374-383, 1980.
70. Duell, E. A., Aström, A., Griffiths, C. E. M., Chambon, P., and Voorhees, J. J. Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vivo. J. Clin. Invest., 90: 1269-1274, 1992.
71. Wouters, W., van Dun, D., Dillen, A., Coene, M-C., Cools, W., and De Coster, R. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res., 52: 2841-2846, 1992.
72. Martin, R., and Murray, M. Retinal dehydrogenation and retinoic acid 4-hydroxylation in rat hepatic microsomes: developmental studies and effect of foreign compounds on the activities. Biochem. Pharmacol., 47: 905-909, 1994.
73. Graham, M. A., Riley, R. J., and Kerr, D. J. Drug metabolism in carcinogenesis and chemotherapy. Pharmacol. Ther., 51: 275-289, 1991.
74. Van Wauwe, J. P., Coene, M. C., Goossens, J., Cools, W., and Monbaliu, J. Effects of cytochrome P-450 on the in vivo metabolism of all-trans-retinoic acid in rats. J. Pharmacol. Exp. Ther., 252: 365-369, 1990.
75. Takatsula, J., Takahashi, N., and De Luca, L. M. Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res., 56: 675-678, 1996.
76. Jing, Y., Zhang, J., Bleiweiss, I. J., Waxman, S., Zelent, A., and Mira-y-Lopez, R. Defective expression of cellular retinol binding protein type I and retinoic acid receptors α2, β2, and γ2 in human breast cancer cells. FASEB J., 10: 1064-1070, 1996.